2061 related articles for article (PubMed ID: 31121890)
1. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
2. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
[TBL] [Abstract][Full Text] [Related]
3. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
4. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
5. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models.
Khandelwal PJ; Herman AM; Hoe HS; Rebeck GW; Moussa CE
Hum Mol Genet; 2011 Jun; 20(11):2091-102. PubMed ID: 21378096
[TBL] [Abstract][Full Text] [Related]
6. Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.
Kerr JS; Adriaanse BA; Greig NH; Mattson MP; Cader MZ; Bohr VA; Fang EF
Trends Neurosci; 2017 Mar; 40(3):151-166. PubMed ID: 28190529
[TBL] [Abstract][Full Text] [Related]
7. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
Reddy PH
Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
[TBL] [Abstract][Full Text] [Related]
8. March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
Eckert A; Nisbet R; Grimm A; Götz J
Biochim Biophys Acta; 2014 Aug; 1842(8):1258-66. PubMed ID: 24051203
[TBL] [Abstract][Full Text] [Related]
9. Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: implications to synaptic dysfunction and neuronal damage.
Manczak M; Reddy PH
J Alzheimers Dis; 2013; 36(2):285-95. PubMed ID: 23594602
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.
Silva DF; Esteves AR; Oliveira CR; Cardoso SM
Curr Alzheimer Res; 2011 Aug; 8(5):563-72. PubMed ID: 21244356
[TBL] [Abstract][Full Text] [Related]
11. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
14. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
Manczak M; Calkins MJ; Reddy PH
Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein.
Grimm A; Biliouris EE; Lang UE; Götz J; Mensah-Nyagan AG; Eckert A
Cell Mol Life Sci; 2016 Jan; 73(1):201-15. PubMed ID: 26198711
[TBL] [Abstract][Full Text] [Related]
16. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
[TBL] [Abstract][Full Text] [Related]
17. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
[TBL] [Abstract][Full Text] [Related]
18. Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
Eckert A; Schulz KL; Rhein V; Götz J
Mol Neurobiol; 2010 Jun; 41(2-3):107-14. PubMed ID: 20217279
[TBL] [Abstract][Full Text] [Related]
19. Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer's disease.
Verma H; Gangwar P; Yadav A; Yadav B; Rao R; Kaur S; Kumar P; Dhiman M; Taglialatela G; Mantha AK
Mitochondrion; 2023 Nov; 73():19-29. PubMed ID: 37708950
[TBL] [Abstract][Full Text] [Related]
20. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.
Manczak M; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
